GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate

24 Sep 2024 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificate, as details enclosed. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2390.85 11.00 (0.46%)
23-Jan-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.15
Dr. Reddys Lab 1218.15
Cipla 1367.25
Zydus Lifesciences 889.95
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×